Shedding light on tumor targeting by adenovirus

Molecular Therapy

Volumn 15, Issue 5, 2007, Pages 841-842

  Baker, Andrew H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; HERPESVIRUS VECTOR; IMATINIB; ONCOLYTIC VIRUS; VIRUS VECTOR;

CANCER; CANCER GENE THERAPY; CANCER INHIBITION; CELL INTERACTION; DRUG EFFICACY; DRUG TARGETING; EDITORIAL; EPSTEIN BARR VIRUS; GENETIC ENGINEERING; MOLECULAR INTERACTION; NONHUMAN; ONCOLYTIC VIROTHERAPY; PROMOTER REGION; PROTEIN BINDING; TRANSCRIPTION REGULATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; GENE THERAPY; GENETIC VECTORS; HUMANS; NEOPLASMS; RECOMBINANT FUSION PROTEINS;

ADENOVIRIDAE;

EID: 34247225945     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300158     Document Type: Editorial

References (3)

1. Mocanu, JD, Yip, KW, Alajez, NM, Shi, W, Li, J-H, Lunt, SJ et al. (2007). Imaging the modulation of adenoviral kinetics and biodistribution for cancer gene therapy. Mol Ther 15: 921-929.
2. Nicklin, SA, Wu, E, Nemerow, G and Baker, AH (2005). The influence of adenovirus fiber structure and function on vector development for gene therapy. Mol Ther 12: 384-393.
3. Gaggar, A, Shayakhmetov, DM and Lieber, A (2003). CD46 is a cellular receptor for group B adenoviruses. Nat Med 9: 1-5.